Webinar banner
Expanding preclinical and histopathology capabilities with MRI technology: a useful tool for preclinical safety and efficacy evaluation


Apr 16, 2019 09:14 AM

Webinar logo
* Required information


Dr. Abraham Nyska
DVM, Dipl. ECVP, Fellow IATP @Tel Aviv University
Dr. Abraham Nyska is an expert in toxicological pathology with more than 40 years of experience in the preclinical pathological evaluation and risk assessment of drugs, chemicals, medical devices, and stem cells. He worked for 18 years as a staff scientist and consultant at the American National Toxicology Program of the National Institute of Health, and continues working as a consultant in toxicologic pathology to a variety of pharmaceutical companies, contract research organizations, and federal institutes in Israel, Europe, India, and North America. He is currently a visiting full professor of pathology at Tel Aviv University in Israel, and is a co-author on more than 440 peer reviewed publications and/or book chapters.